CANCER GENETICS

CGIX NASDAQ
0.1700
+0.0001
+0.06%
已收盘, 16:00 06/24 EDT
开盘
0.1650
昨收
0.1699
最高
0.1916
最低
0.1650
成交量
47.06万
成交均量(3M)
146.12万
52周最高
1.300
52周最低
0.1518
换手率
0.81%
市值
982.87万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供CANCER GENETICS CGIX股票价格,CANCER GENETICS股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Cancer Genetics, Inc. is a United States-based company, which is engaged in the field of personalized medicine. The Company offers diagnostic products and services that enable precision medicine in the field of oncology through molecular markers and diagnostics. The Company offers a range of laboratory services that provide genomic and biomarker information. Its Select One Clinical Trials program provides a range of integrated and dynamic clinical trial services for both oncology and non-oncology genetic testing for Phase I-III trials along with ancillary services, including bioinformatics, biorepository and trials logistic support. The Company is developing a global footprint with locations in the United States, India and China. It also offers a portfolio of genotyping services, with access to over 400 validated genotyping assays, including Phase I and Phase II drug metabolizing enzymes, transporters, and receptors, and over 30 validated gene expression assays.
展开 >

最近浏览

名称
价格
涨跌幅